- Home
- CPRX vs DHT Comparison
CPRX vs DHT Comparison
Compare CPRX & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | DHT |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.9B |
| IPO Year | 2006 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CPRX | DHT |
|---|---|---|
| Price | $31.17 | $18.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $35.00 | $19.33 |
| AVG Volume (30 Days) | 2.3M | ★ 3.0M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.36% |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 1.68 | N/A |
| Revenue | ★ $119,072,803.00 | N/A |
| Revenue This Year | $9.20 | $8.85 |
| Revenue Next Year | $10.51 | N/A |
| P/E Ratio | $18.54 | ★ $12.73 |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $10.61 |
| 52 Week High | $32.56 | $20.55 |
Technical Indicators
Market Signals| Indicator | CPRX | DHT |
|---|---|---|
| Relative Strength Index (RSI) | 73.25 | 59.00 |
| Support Level | $22.41 | $16.98 |
| Resistance Level | $32.56 | $20.55 |
| Average True Range (ATR) | 1.30 | 0.65 |
| MACD | 0.30 | 0.07 |
| Stochastic Oscillator | 80.10 | 66.73 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.